Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes.

Diabetes Care · 2013 · PMC3714510 · PMID 23514733

Europe PMC DOI

hedged sentences

0.1170

closest p · 2.3× alpha

0.1170

boldest claim

The sentences

did not reach statistical significanceP = 0.117not close (p > 0.1)

2 B ) but did not reach statistical significance ( P = 0.117).

also in 111,027 other papers

showed a trendno p-value reported

The ratio of the total area under the curve (AUC) for insulin to the total AUC for glucose showed a trend toward a positive LY effect ( Fig. 2 B ) but did not reach statistical significance ( P = 0.117).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.